UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children: Executive Summary

Clinical infectious diseases, 2011-02, Vol.52 (3), p.285-292

2011

Volltextzugriff (PDF)

The β-Lactams Strike Back: Ceftazidime-Avibactam

Pharmacotherapy, 2015-08, Vol.35 (8), p.755-770

2015

Volltextzugriff (PDF)

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

Clinical infectious diseases, 2011-02, Vol.52 (3), p.e18-e55

2011

Volltextzugriff (PDF)

The Pharmacokinetic and Pharmacodynamic Properties of Vancomycin

Clinical infectious diseases, 2006-01, Vol.42 (Supplement-1), p.S35-S39

Rybak, Michael J

2006

Volltextzugriff (PDF)

The [beta]-Lactams Strike Back: Ceftazidime-Avibactam

Pharmacotherapy, 2015-08, Vol.35 (8), p.755

2015

Volltextzugriff (PDF)

Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

Clinical infectious diseases, 2020-09, Vol.71 (6), p.1361-1364

2020

Volltextzugriff (PDF)

Understanding vancomycin nephrotoxicity augmented by β-lactams: a synthesis of endosymbiosis, proximal renal tubule mitochondrial metabolism, and β-lactam chemistry

The Lancet infectious diseases, 2024-03, Vol.24 (3), p.e179-e188

2024

Volltextzugriff (PDF)

A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity

Antimicrobial agents and chemotherapy, 2017-12, Vol.61 (12)

2017

Volltextzugriff (PDF)

Reply to Scheetz et al

Clinical infectious diseases, 2023-04, Vol.76 (8), p.1522-1523

2023

Volltextzugriff (PDF)

A Review of Combination Antimicrobial Therapy for Enterococcus faecalis Bloodstream Infections and Infective Endocarditis

Clinical infectious diseases, 2018-07, Vol.67 (2), p.303-309

2018

Volltextzugriff (PDF)

Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

American journal of health-system pharmacy, 2020-05, Vol.77 (11), p.835-864

2020

Volltextzugriff (PDF)

Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous Vancomycin

Antimicrobial agents and chemotherapy, 2018-01, Vol.62 (1)

2018

Volltextzugriff (PDF)

Bacteriophage Therapeutics: A Primer for Clinicians on Phage‐Antibiotic Combinations

Pharmacotherapy, 2020-02, Vol.40 (2), p.153-168

2020

Volltextzugriff (PDF)

β-Lactam Combinations with Vancomycin Show Synergistic Activity against Vancomycin-Susceptible Staphylococcus aureus, Vancomycin-Intermediate S. aureus (VISA), and Heterogeneous VISA

Antimicrobial agents and chemotherapy, 2018-06, Vol.62 (6)

2018

Volltextzugriff (PDF)

Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association

Circulation (New York, N.Y.), 2015-10, Vol.132 (15), p.1435-1486

2015

Volltextzugriff (PDF)

Evaluation of the Synergy of Ceftazidime-Avibactam in Combination with Meropenem, Amikacin, Aztreonam, Colistin, or Fosfomycin against Well-Characterized Multidrug-Resistant Klebsiella pneumoniae and Pseudomonas aeruginosa

Antimicrobial agents and chemotherapy, 2019-08, Vol.63 (8)

2019

Volltextzugriff (PDF)

Impact of Vancomycin Exposure on Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets

Clinical infectious diseases, 2011-04, Vol.52 (8), p.975-981

2011

Volltextzugriff (PDF)

Panacea or oversimplification: Relating AUC and troughs

American journal of health-system pharmacy, 2022-06, Vol.79 (12), p.1019-1021

2022

Volltextzugriff (PDF)

Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists

Clinical infectious diseases, 2009-08, Vol.49 (3), p.325-327

2009

Volltextzugriff (PDF)

Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin–Tazobactam Compared to Those on Vancomycin and Cefepime

Clinical infectious diseases, 2017-01, Vol.64 (2), p.116-123

2017

Volltextzugriff (PDF)

Considerations for the Use of Phage Therapy in Clinical Practice

Antimicrobial agents and chemotherapy, 2022-03, Vol.66 (3), p.e0207121-e0207121

2022

Volltextzugriff (PDF)

Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa

Infectious diseases and therapy, 2022-04, Vol.11 (2), p.661-682

2022

Volltextzugriff (PDF)

Role of Combination Antimicrobial Therapy for Vancomycin‐Resistant Enterococcus faecium Infections: Review of the Current Evidence

Pharmacotherapy, 2017-05, Vol.37 (5), p.579-592

2017

Volltextzugriff (PDF)

Ceftaroline Increases Membrane Binding and Enhances the Activity of Daptomycin against Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model

Antimicrobial Agents and Chemotherapy, 2013-01, Vol.57 (1), p.66-73

2013

Volltextzugriff (PDF)

Novel approaches for the treatment of methicillin-resistant Staphylococcus aureus: Using nanoparticles to overcome multidrug resistance

Drug discovery today, 2021-01, Vol.26 (1), p.31-43

2021

Volltextzugriff (PDF)

1 – 25 von 799

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(752)
Mit Volltextzugriff
(715)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(795)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(565)
Life Sciences & Biomedicine
(529)
Humans
(355)
Pharmacology & Pharmacy
(291)
Microbiology
(247)
Biological And Medical Sciences
(217)
Medical Sciences
(206)
Infectious Diseases
(205)
Microbial Sensitivity Tests
(180)
Pharmacology. Drug Treatments
(168)
Anti-Bacterial Agents - Pharmacology
(155)
Staphylococcus Aureus
(144)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(142)
Male
(136)
Female
(132)
Middle Aged
(107)
Adult
(106)
Anti-Bacterial Agents - Therapeutic Use
(93)
Staphylococcus Aureus - Drug Effects
(89)
Antibacterial Agents
(87)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children: Executive Summary

The β-Lactams Strike Back: Ceftazidime-Avibactam

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

The Pharmacokinetic and Pharmacodynamic Properties of Vancomycin

The [beta]-Lactams Strike Back: Ceftazidime-Avibactam

Understanding vancomycin nephrotoxicity augmented by β-lactams: a synthesis of endosymbiosis, proximal renal tubule mitochondrial metabolism, and β-lactam chemistry

A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity

Reply to Scheetz et al

A Review of Combination Antimicrobial Therapy for Enterococcus faecalis Bloodstream Infections and Infective Endocarditis

Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous Vancomycin

Bacteriophage Therapeutics: A Primer for Clinicians on Phage‐Antibiotic Combinations

β-Lactam Combinations with Vancomycin Show Synergistic Activity against Vancomycin-Susceptible Staphylococcus aureus, Vancomycin-Intermediate S. aureus (VISA), and Heterogeneous VISA

Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association

Evaluation of the Synergy of Ceftazidime-Avibactam in Combination with Meropenem, Amikacin, Aztreonam, Colistin, or Fosfomycin against Well-Characterized Multidrug-Resistant Klebsiella pneumoniae and Pseudomonas aeruginosa

Impact of Vancomycin Exposure on Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets

Panacea or oversimplification: Relating AUC and troughs

Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists

Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin–Tazobactam Compared to Those on Vancomycin and Cefepime

Considerations for the Use of Phage Therapy in Clinical Practice

Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa

Role of Combination Antimicrobial Therapy for Vancomycin‐Resistant Enterococcus faecium Infections: Review of the Current Evidence

Ceftaroline Increases Membrane Binding and Enhances the Activity of Daptomycin against Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model

Novel approaches for the treatment of methicillin-resistant Staphylococcus aureus: Using nanoparticles to overcome multidrug resistance

Suchergebnisse filtern